Breaking News, Collaborations & Alliances

Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines

The annual production is expected to exceed 100 million finished doses annually for Latin America.

Author Image

By: Charlie Sternberg

Associate Editor

Pfizer Inc. and BioNTech SE have signed of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY (COVID-19 vaccine, mRNA) (BNT162b2) for distribution within Latin America.    Terms of the Agreement   Eurofarma will perform manufacturing activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span four continents and include more than 20 manufacturing facilities. To facili...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters